organophosphonates has been researched along with 3-amino-4-(3-hexylphenylamino)-4-oxobutylphosphonic acid in 27 studies
Studies (organophosphonates) | Trials (organophosphonates) | Recent Studies (post-2010) (organophosphonates) | Studies (3-amino-4-(3-hexylphenylamino)-4-oxobutylphosphonic acid) | Trials (3-amino-4-(3-hexylphenylamino)-4-oxobutylphosphonic acid) | Recent Studies (post-2010) (3-amino-4-(3-hexylphenylamino)-4-oxobutylphosphonic acid) |
---|---|---|---|---|---|
9,968 | 880 | 3,596 | 27 | 0 | 24 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (7.41) | 29.6817 |
2010's | 23 (85.19) | 24.3611 |
2020's | 2 (7.41) | 2.80 |
Authors | Studies |
---|---|
Cahalan, MD; Cheng, WC; Don, A; Gonzalez-Cabrera, PJ; Jo, E; Marsolais, D; Matheu, MP; Parker, I; Rosen, H; Sanna, MG; Wang, SK; Wei, SH; Wong, CH | 1 |
Schultz, C | 1 |
He, P; Qian, Y; Xu, S; Zhang, G | 1 |
Chen, Z; Doyle, T; Finley, A; Salvemini, D | 1 |
Chen, Z; Doyle, T; Obeid, LM; Salvemini, D | 1 |
Aguilar, N; Aulí, M; Calbet, M; Dolgachev, V; Domènech, MT; Domínguez, M; Godessart, N; Kunkel, SL; López, R; Milligan, G; Mustafa, S; Pont, M; Prats, N; Tarrasón, G | 1 |
Cahalan, SM; Clemons, B; Desale, H; Griffith, MT; Han, GW; Hanson, MA; Jo, E; Kuhn, P; Reinhart, G; Rosen, H; Roth, CB; Sanna, MG; Schuerer, SC; Scott, FL; Stevens, RC | 1 |
Lima, S; Parrill, AL; Spiegel, S | 1 |
Chi, XX; Li, C; Nicol, GD; Strong, JA; Xie, W; Zhang, JM | 1 |
Alewijnse, AE; Buraschi, S; Chiodelli, P; Dell'era, P; Foglia, E; Mitola, S; Nicoli, S; Presta, M; Tobia, C; van Loenen, PB | 1 |
Brown, JD; Francis, SA; Michel, T; Natarajan, P; Plutzky, J; Rader, DJ; Saghatelian, A; Tatematsu, S | 1 |
Felding, BH; Gay, LJ; Nguyen, N; Rosen, H; Sarkisyan, G | 1 |
Bieberich, E; Bryant, L; Chen, C; Chen, Z; Cuzzocrea, S; Doyle, T; Esposito, E; Janes, K; Kamocki, K; Li, C; Little, JW; Neumann, WL; Nicol, G; Obeid, L; Petrache, I; Salvemini, D; Snider, A | 1 |
Haufe, G; Hermann, S; Keul, P; Levkau, B; Prasad, VP; Schäfers, M; Wagner, S | 1 |
Ferreirós, N; Geisslinger, G; Henke, M; Linke, B; Scholich, K; Schreiber, Y; Stark, H; Suo, J; Zhang, DD; Zivkovic, A | 1 |
Guerrero, M; Kays, J; Li, C; Li, JN; Nicol, GD | 1 |
Attiori Essis, S; Cyr, M; Laurier-Laurin, ME; Massicotte, G; Pépin, É | 1 |
Gao, P; Kang, Y; Li, Y; Ning, Z; Ren, T; Sun, M; Xiang, B; Xie, P; Zhu, W | 1 |
Cotta-de-Almeida, V; Lemos, JP; Mendes-da-Cruz, DA; Messias, CV; Moreira, OC; Santana-Van-Vliet, E; Savino, W | 1 |
Fu, Y; Han, W; Hao, J; Huang, D; Liu, Q; Shen, Y; Sheth, KN; Shi, FD; Shi, K; Sun, N; Wood, K | 1 |
Klöckl, L; Schuchardt, M; Tölle, M; van der Giet, M; Wiedon, A; Zidek, W | 1 |
Böhm, A; Dannenberg, L; Kelm, M; Knoop, B; Levkau, B; Polzin, A; Rauch, BH; Zeus, T; Zurek, M | 1 |
Donahue, RR; Doolen, S; Grachen, CM; Iannitti, T; Shaw, BC; Taylor, BK | 1 |
Fu, J; Gao, F; Gao, Y; Li, Y; Meng, F; Yang, C | 1 |
Chung, H; Jo, DI; Jung, SH; Kim, B; Kim, SH; Ko, HM; Lee, DH; Lee, SH; Song, YK | 1 |
Gräler, MH; Guntinas-Lichius, O; Jeya Paul, J; Thuy, AV; Weigel, C; Ziegler, AC | 1 |
Birch, CA; Chen, B; Cisneros-Aguirre, M; Coronel, LJ; Gomez Menzies, PK; Grimsey, NJ; Lawson, MA; Lin, H; Molinar-Inglis, O; Nicholas, D; Orduña-Castillo, L; Patel, HH; Patwardhan, A; Trejo, J | 1 |
27 other study(ies) available for organophosphonates and 3-amino-4-(3-hexylphenylamino)-4-oxobutylphosphonic acid
Article | Year |
---|---|
Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo.
Topics: Anilides; Animals; Capillary Permeability; Cells, Cultured; CHO Cells; Cricetinae; Disease Models, Animal; Evans Blue; Humans; Lymph Nodes; Lymphocytes; Lysophospholipids; Mice; Mice, Inbred C57BL; Models, Biological; Organophosphonates; Phenotype; Pulmonary Edema; Receptors, Lysosphingolipid; Sphingosine; Stereoisomerism | 2006 |
Lipid-induced phenotypes.
Topics: Anilides; Animals; Binding Sites; Humans; Lysophospholipids; Models, Biological; Organophosphonates; Phenotype; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine | 2006 |
Sphingosine-1-phosphate prevents permeability increases via activation of endothelial sphingosine-1-phosphate receptor 1 in rat venules.
Topics: Anilides; Animals; Calcium; Capillary Permeability; Endothelium, Vascular; Female; Lysophospholipids; Mesentery; Models, Animal; Organophosphonates; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Sphingosine; Venules | 2010 |
Role for peroxynitrite in sphingosine-1-phosphate-induced hyperalgesia in rats.
Topics: Acetophenones; Anilides; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Activation; Enzyme Inhibitors; Hyperalgesia; Lysophospholipids; Male; Metalloporphyrins; NG-Nitroarginine Methyl Ester; Organophosphonates; Oxadiazoles; Peroxynitrous Acid; Rats; Rats, Sprague-Dawley; Reaction Time; Receptors, Lysosphingolipid; Sphingosine; Thiophenes; Time Factors | 2011 |
Sphingosine-1-phosphate acting via the S1P₁ receptor is a downstream signaling pathway in ceramide-induced hyperalgesia.
Topics: Anilides; Animals; Ceramides; Hyperalgesia; Inflammation Mediators; Injections, Subcutaneous; Lysophospholipids; Male; Mice; Organophosphonates; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine | 2011 |
The sphingosine-1-phosphate receptor-1 antagonist, W146, causes early and short-lasting peripheral blood lymphopenia in mice.
Topics: Anilides; Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chemotaxis; Flow Cytometry; Lymph Nodes; Lymphocyte Count; Lymphocytes; Lymphopenia; Male; Mice; Organophosphonates; Receptors, Lysosphingolipid; Thymus Gland; Time Factors | 2011 |
Crystal structure of a lipid G protein-coupled receptor.
Topics: Anilides; Binding Sites; Crystallography, X-Ray; Models, Molecular; Muramidase; Mutagenesis; Organophosphonates; Protein Conformation; Receptors, Lysosphingolipid; Recombinant Fusion Proteins | 2012 |
Structure of the first sphingosine 1-phosphate receptor.
Topics: Anilides; Binding Sites; Crystallography, X-Ray; Drug Design; Humans; Indans; Lysophospholipids; Models, Molecular; Organophosphonates; Oxadiazoles; Protein Binding; Protein Conformation; Receptors, Lysosphingolipid; Sphingosine | 2012 |
Sphingosine 1-phosphate receptor 2 antagonist JTE-013 increases the excitability of sensory neurons independently of the receptor.
Topics: Action Potentials; Analysis of Variance; Anilides; Animals; Capsaicin; Cell Line, Tumor; Cell Movement; Dinoprostone; Dose-Response Relationship, Drug; Drug Interactions; Ganglia, Spinal; Guanosine Diphosphate; Hyperalgesia; Lysophospholipids; Male; Melanoma; Mice; Organophosphonates; Pain Threshold; Patch-Clamp Techniques; Pertussis Toxin; Pyrazoles; Pyridines; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Sensory Receptor Cells; Sensory System Agents; Sphingosine; Thionucleotides; Time Factors; Wound Healing | 2012 |
Sphingosine-1-phosphate receptor-1 controls venous endothelial barrier integrity in zebrafish.
Topics: Anilides; Animals; Animals, Genetically Modified; Antigens, CD; Cadherins; Capillary Permeability; CHO Cells; Cricetinae; Cricetulus; Endothelial Cells; Gene Expression Regulation, Developmental; Green Fluorescent Proteins; Human Umbilical Vein Endothelial Cells; Humans; Membrane Proteins; Morpholinos; Oligonucleotides, Antisense; Organophosphonates; Phosphoproteins; Receptor, EphB4; Receptors, Lysosphingolipid; RNA Interference; Sphingosine-1-Phosphate Receptors; Tight Junctions; Transfection; Veins; Zebrafish; Zebrafish Proteins; Zonula Occludens-1 Protein | 2012 |
Endothelial lipase is a critical determinant of high-density lipoprotein-stimulated sphingosine 1-phosphate-dependent signaling in vascular endothelium.
Topics: Anilides; Animals; Cell Movement; Cell Proliferation; Cells, Cultured; Cholesterol; Endothelium, Vascular; Lipase; Lipoproteins, HDL; Lysophospholipids; Mice; Mice, Knockout; Neovascularization, Physiologic; Nitric Oxide Synthase Type III; Organophosphonates; Phosphorylation; Proto-Oncogene Proteins c-akt; Receptors, Lysosphingolipid; RNA, Small Interfering; Signal Transduction; Sphingosine | 2013 |
Host endothelial S1PR1 regulation of vascular permeability modulates tumor growth.
Topics: Anilides; Animals; Breast Neoplasms; Capillary Permeability; Endothelial Cells; Female; Green Fluorescent Proteins; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplastic Cells, Circulating; Neovascularization, Pathologic; Organophosphonates; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine-1-Phosphate Receptors; Time Factors; Tumor Burden | 2014 |
The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1.
Topics: Anilides; Animals; Antineoplastic Agents, Phytogenic; Cytokines; Enzyme Activation; Fingolimod Hydrochloride; Humans; Immunosuppressive Agents; Indans; Lysophospholipids; Male; Neuralgia; Organophosphonates; Oxadiazoles; Paclitaxel; Propylene Glycols; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors; Thiazoles; Thiophenes | 2014 |
Synthesis of fluorinated analogues of sphingosine-1-phosphate antagonists as potential radiotracers for molecular imaging using positron emission tomography.
Topics: Anilides; Animals; Cells, Cultured; CHO Cells; Cricetulus; Dose-Response Relationship, Drug; Fluorine Radioisotopes; Halogenation; Humans; Male; Mice; Mice, Inbred C57BL; Molecular Imaging; Molecular Structure; Organophosphonates; Positron-Emission Tomography; Radiopharmaceuticals; Receptors, Lysosphingolipid; Structure-Activity Relationship; Tissue Distribution | 2014 |
Antinociceptive effects of FTY720 during trauma-induced neuropathic pain are mediated by spinal S1P receptors.
Topics: Analgesics; Anilides; Animals; In Situ Hybridization; Lysophospholipids; Male; Mice; Neuralgia; Organophosphates; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Receptors, Lysosphingolipid; Signal Transduction; Sphingosine; Wounds and Injuries | 2015 |
Sphingosine 1-phosphate enhances the excitability of rat sensory neurons through activation of sphingosine 1-phosphate receptors 1 and/or 3.
Topics: Action Potentials; Anilides; Animals; Cells, Cultured; Dinoprostone; Enzyme Inhibitors; Fingolimod Hydrochloride; Ganglia, Spinal; Gene Expression Regulation; Immunosuppressive Agents; Lysophospholipids; Mice; Mice, Inbred C57BL; Organophosphonates; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; RNA, Small Interfering; Sensory Receptor Cells; Sphingosine; Sphingosine-1-Phosphate Receptors; Thiazolidines | 2015 |
GluN2B-containing NMDA receptors are upregulated in plasma membranes by the sphingosine-1-phosphate analog FTY720P.
Topics: Analysis of Variance; Anilides; Animals; Biotinylation; Cell Membrane; Enzyme Inhibitors; Hippocampus; In Vitro Techniques; Lysophospholipids; Male; Organophosphates; Organophosphonates; Phosphorylation; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Receptors, N-Methyl-D-Aspartate; Sphingosine; Sphingosine-1-Phosphate Receptors; src-Family Kinases; Time Factors; Transcriptional Activation; Up-Regulation | 2015 |
S1PR1 expression correlates with inflammatory responses to Newcastle disease virus infection.
Topics: Anilides; Animals; Cells, Cultured; Chick Embryo; Cytokines; Fibroblasts; Newcastle Disease; Newcastle disease virus; Organophosphonates; Poultry Diseases; Receptors, Lysosphingolipid; Up-Regulation | 2016 |
Sphingosine-1-Phosphate Induces Dose-Dependent Chemotaxis or Fugetaxis of T-ALL Blasts through S1P1 Activation.
Topics: Anilides; Cell Line, Tumor; Chemotaxis; Gene Expression Regulation, Leukemic; Humans; Lysophospholipids; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Organophosphonates; Phosphorylation; Proto-Oncogene Proteins c-akt; rac1 GTP-Binding Protein; Receptors, Lysosphingolipid; RNA, Messenger; Signal Transduction; Sphingosine; T-Lymphocytes | 2016 |
Selective Sphingosine-1-Phosphate Receptor 1 Modulation Attenuates Experimental Intracerebral Hemorrhage.
Topics: Anilides; Animals; Apoptosis; Blood-Brain Barrier; Brain Edema; Cerebral Hemorrhage; Cytokines; DNA-Binding Proteins; Drug Evaluation, Preclinical; Lymphocyte Subsets; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; Neurons; Organophosphonates; Receptors, Lysosphingolipid; Sphingosine-1-Phosphate Receptors | 2016 |
Regulation of endothelial nitric oxide synthase activation in endothelial cells by S1P1 and S1P3.
Topics: Anilides; beta-Alanine; Endothelial Cells; Enzyme Activation; Gene Knockdown Techniques; Human Umbilical Vein Endothelial Cells; Humans; Nitric Oxide; Nitric Oxide Synthase Type III; Organophosphates; Organophosphonates; Phosphorylation; Phosphoserine; Proto-Oncogene Proteins c-akt; Receptors, Lysosphingolipid; RNA, Small Interfering; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors; Thiazolidines; Thiophenes | 2016 |
Aspirin Inhibits Platelet-Derived Sphingosine-1-Phosphate Induced Endothelial Cell Migration.
Topics: Anilides; Aspirin; Blood Platelets; Cell Movement; Cells, Cultured; Human Umbilical Vein Endothelial Cells; Humans; Lysophospholipids; Organophosphonates; Receptors, Lysosphingolipid; Sphingosine | 2018 |
Fingolimod reduces neuropathic pain behaviors in a mouse model of multiple sclerosis by a sphingosine-1 phosphate receptor 1-dependent inhibition of central sensitization in the dorsal horn.
Topics: Anilides; Animals; Central Nervous System Sensitization; Disease Models, Animal; eIF-2 Kinase; Female; Fingolimod Hydrochloride; Immunosuppressive Agents; Male; Mice; Mice, Inbred C57BL; Motor Activity; Multiple Sclerosis; Myelin-Oligodendrocyte Glycoprotein; Neuralgia; Organophosphonates; Oxadiazoles; Pain Threshold; Peptide Fragments; Receptors, Lysosphingolipid; Sphingosine-1-Phosphate Receptors; Spinal Cord; Spinal Nerve Roots; Subcellular Fractions; Thiophenes | 2018 |
The Sphingosine 1-Phosphate Analogue FTY720 Alleviates Seizure-induced Overexpression of P-Glycoprotein in Rat Hippocampus.
Topics: Anilides; Animals; Anticonvulsants; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclooxygenase 2; Disease Models, Animal; Drug Resistant Epilepsy; Fingolimod Hydrochloride; Hippocampus; Humans; Immunosuppressive Agents; Injections, Intraperitoneal; Lysophospholipids; Male; Organophosphonates; Phenytoin; Pilocarpine; Rats; Rats, Sprague-Dawley; Receptors, Lysosphingolipid; Sphingosine; Sphingosine-1-Phosphate Receptors; Up-Regulation | 2018 |
Association between sphingosine-1-phosphate-induced signal transduction via mitogen-activated protein kinase pathways and keloid formation.
Topics: Adult; Anilides; Anthracenes; Cell Line; Collagen Type I; Collagen Type I, alpha 1 Chain; Female; Fibroblasts; Flavonoids; Humans; Keloid; Lysophospholipids; Male; MAP Kinase Signaling System; Middle Aged; Mitogen-Activated Protein Kinases; Organophosphonates; Phosphorylation; Pyrazoles; Pyridines; Signal Transduction; Sphingosine; Sphingosine-1-Phosphate Receptors; Young Adult | 2019 |
Validation of a monoclonal antibody directed against the human sphingosine 1-phosphate receptor type 1.
Topics: Anilides; Animals; Antibodies, Monoclonal; B-Lymphocytes; Burkitt Lymphoma; Endothelial Cells; Gene Expression Regulation; Human Umbilical Vein Endothelial Cells; Humans; Immunoglobulin M; Mice; Organ Specificity; Organophosphonates; Palatine Tonsil; Sphingosine-1-Phosphate Receptors; T-Lymphocytes | 2021 |
aPC/PAR1 confers endothelial anti-apoptotic activity via a discrete, β-arrestin-2-mediated SphK1-S1PR1-Akt signaling axis.
Topics: Anilides; Apoptosis; beta-Arrestin 2; Endothelial Cells; Enzyme Inhibitors; Gene Expression Regulation; Heterocyclic Compounds, 3-Ring; Humans; Lactones; Methanol; Organophosphonates; Phosphotransferases (Alcohol Group Acceptor); Platelet Aggregation Inhibitors; Protein C; Proto-Oncogene Proteins c-akt; Pyridines; Pyrrolidines; Receptor, PAR-1; Sphingosine-1-Phosphate Receptors; Sulfones | 2021 |